Application of tulasi extract in preparation of medicament for treating radiation injuries
A technology of radiation damage and extracts, which is applied in the direction of drug combinations, pharmaceutical formulas, plant raw materials, etc., to achieve good drug safety, improve survival rate, and reduce radiation damage.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0018] The experimental animal Swiss mouse (Swiss albino mice) used in the examples was provided by the Animal Experiment Center of Soochow University.
[0019] The reagents and instruments used in the examples include: Reagents: Tulasi leaf extract is provided by Suzhou Kimov Drug Development Co., Ltd., High-tech Zone, Suzhou City, Jiangsu Province. Malondialdehyde (Malondialdehyde, MDA) assay kit, reduced glutathione (Glutathione, GSH) assay kit, coomassie bright blue protein assay kit were all provided by Nanjing Jiancheng Bioengineering Institute. Instrument: Model 722 visible spectrophotometer is produced by Shanghai Second Instrument Factory.
[0020] use 137 Cs-γ ray irradiated mice with different doses of a single whole body, and used the maximum tolerated dose to evaluate the drug safety of Tulasi, and observed the 30-day survival rate of mice, liver malondialdehyde (MDA) and reduced glutathione (Glutathione, GSH) content.
[0021] In the above technical scheme, th...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com